Replies to post #92231 on Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

Again, I disagree, I don't think the first cohort of a phase I trial can really explain any of those, as it's just not anywhere near enough information. Your second #2 is just ridiculous, they may have concluded that for other reasons, but not based on the NEO trial.